Gusella, M., Pasini, F., Bolzonella, C., Meneghetti, S., Barile, C., Bononi, A., . . . Padrini, R. (2011). Equilibrative nucleoside transporter 1 genotype, cytidine deaminase activity and age predict gemcitabine plasma clearance in patients with solid tumours. Blackwell Science Inc.
シカゴスタイル引用形Gusella, Milena, et al. Equilibrative Nucleoside Transporter 1 Genotype, Cytidine Deaminase Activity and Age Predict Gemcitabine Plasma Clearance in Patients With Solid Tumours. Blackwell Science Inc, 2011.
MLA引用形式Gusella, Milena, et al. Equilibrative Nucleoside Transporter 1 Genotype, Cytidine Deaminase Activity and Age Predict Gemcitabine Plasma Clearance in Patients With Solid Tumours. Blackwell Science Inc, 2011.
警告: この引用は必ずしも正確ではありません.